Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

The extract promoted hair growth without significant toxicity.

The treatment showed promising results in improving advanced-stage hair loss.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

A new treatment using special nanovesicles with linoleic acid shows promise in improving hair growth and reducing irritation for hair loss.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

The fragrance cyclohexyl salicylate helps promote hair growth and increase hair stem cell numbers.

COX-2 and Bcl-2 proteins are involved in Lichen Planus.

Two patients with Cronkhite-Canada syndrome achieved remission after treatment.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Removing EGFR in skin causes inflammation and abnormal hair growth.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Cedrol nanoemulsions effectively treat hair loss by promoting hair growth and reducing DHT levels safely.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

The new patch made of cell matrix and a polymer improves wound healing and supports blood vessel growth.

CMC2.24 and CMC2.23 reduce melanin safely and effectively.

The man's diarrhea was caused by a rare disorder called Cronkhite-Canada syndrome, which improved with specific medications.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

A woman with CCCA has hair loss due to factors like straighteners and tight hairstyles, and treatments include steroids and avoiding certain hair products.

A new hair loss treatment combining minoxidil and cedrol improves hair growth and reduces side effects.

CCCA is a common, scarring hair loss in Black women that needs early detection.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

CCC1 is essential for pH balance and normal cell function in plants.